Literature DB >> 33131264

COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.

.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33131264     DOI: 10.3324/haematol.2020.254250

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  COVID-19 infection in patients with severe aplastic anaemia.

Authors:  Casey Paton; Liza Mathews; Emma M Groarke; Olga Rios; Jennifer Lotter; Bhavisha A Patel; Neal S Young
Journal:  Br J Haematol       Date:  2021-04-29       Impact factor: 8.615

2.  Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.

Authors:  Caterina P Minniti; Ahmar U Zaidi; Mehdi Nouraie; Deepa Manwani; Gary D Crouch; Andrew S Crouch; Michael U Callaghan; Sarah Carpenter; Charleen Jacobs; Jin Han; Jena Simon; Jeffrey Glassberg; Victor R Gordeuk; Elizabeth S Klings
Journal:  Blood Adv       Date:  2021-01-12

Review 3.  Hemoglobinopathy and pediatrics in the time of COVID-19.

Authors:  Thiago de Souza Vilela; Josefina Aparecida Pellegrini Braga; Sandra Regina Loggetto
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-02

4.  COVID-19 Mortality in a Pediatric Patient with Hemoglobin SC Disease and Alpha-Thalassemia Trait.

Authors:  Joshua E Motelow; Stacie Kahn; Patrick T Wilson
Journal:  Case Rep Crit Care       Date:  2021-04-27

5.  COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals.

Authors:  Ashima Singh; Amanda M Brandow; Julie A Panepinto
Journal:  Blood Adv       Date:  2021-04-13

6.  Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort study.

Authors:  Abdulkarim Abdulrahman; Mohammed Wael; Fajer AlAmmadi; Zahra Almosawi; Reem Alsherooqi; Manal Abduljalil; Nitya Kumar; Manaf AlQahtani
Journal:  EJHaem       Date:  2021-02-10

7.  COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.

Authors:  Kamal Kant Sahu; Laeth George; Nelroy Jones; Ankit Mangla
Journal:  J Med Virol       Date:  2021-02-01       Impact factor: 2.327

Review 8.  Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.

Authors:  Wouter S Hoogenboom; Tharun T Alamuri; Daniel M McMahon; Nino Balanchivadze; Vrushali Dabak; William B Mitchell; Kerry B Morrone; Deepa Manwani; Tim Q Duong
Journal:  Blood Rev       Date:  2021-11-20       Impact factor: 10.626

Review 9.  Sickle cell disease and COVID-19: Susceptibility and severity.

Authors:  Babak Sayad; Mehran Karimi; Zohreh Rahimi
Journal:  Pediatr Blood Cancer       Date:  2021-06-01       Impact factor: 3.838

10.  Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease.

Authors:  Lana Mucalo; Amanda M Brandow; Mahua Dasgupta; Sadie F Mason; Pippa M Simpson; Ashima Singh; Bradley W Taylor; Katherine J Woods; Fouza I Yusuf; Julie A Panepinto
Journal:  Blood Adv       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.